The human mitochondrial genome is replicated by DNA polymerase in concert with key components of the mitochondrial DNA (mtDNA) replication machinery. Defects in mtDNA replication or nucleotide metabolism cause deletions, point mutations, or depletion of mtDNA.
Introduction
Human mitochondrial DNA (mtDNA) occurs as a double stranded negatively supercoiled circular genome of 16,569 base pairs (bp) that encodes 37 genes required for energy production ( Figure 1 ). Thirteen genes encode proteins required for the mitochondrial electron transport chain or oxidative phosphorylation (OXPHOS). The remaining 24 genes encode 22 transfer RNAs and 2 ribosomal RNAs required for synthesis of the 13-mitochondrial polypeptides. A cell can contain several thousand copies of mtDNA distributed within hundreds of individual mitochondria [1] or within an elaborate intracellular network of reticular mitochondria Several proteins associate with mtDNA at distinct nucleoid structures on the matrix-side of the inner membrane [2] , and such protein-mtDNA nucleoids can be visualized as foci or puncta via immunocytochemistry or live-cell fluorescence microscopy [3, 4] .
Mitochondrial disorders can be caused by genetic defects in mtDNA or in nuclear genes that encode proteins that function within mitochondria [5] . A class of genes specifically linked to instability of mtDNA has emerged over the last fifteen years (Table 1) . Disorders associated with multiple mtDNA deletions and point mutations comprise commonly known disorders such as progressive external ophthalmoplegia (PEO) and ataxia-neuropathy syndromes but also some very rare disorders of TCA cycle abnormalities [6] . MtDNA depletion syndromes (MDS) include early childhood disorders such as Alpers-Huttenlocher syndrome (AHS), hepatocerebral syndromes, myocerebrohepatopathy spectrum (MCHS), and fatal myopathies [7, 8] . Mutations in genes required for nucleotide biosynthesis and mitochondrial homeostasis are also linked to MDS and deletion syndrome (Table 1) , although a comprehensive review is beyond the scope of this paper. Here we review the known enzymes and proteins comprising the human mtDNA replication machinery and briefly discuss the current models of mtDNA replication. Attention is focused on mtDNA maintenance disorders associated with mutation of genes encoding components of the mtDNA replication and repair machinery: POLG, POLG2, Twinkle, RNASEH1, DNA2, and MGME1 genes.
The mtDNA replisome
MtDNA is replicated and repaired by the mtDNA polymerase ol Human pol is a heterotrimer consisting of one 140-kDa catalytic subunit (p140 encoded by POLG) and a 110-kDa homodimeric processivity subunit (p55 accessory subunit encoded by POLG2), Figure 1 and Figure 2 . The p140 catalytic subunit harbors active sites for 5'-3' DNA polymerase, 3'-5'
exonuclease, and 5' dRP lyase activities [9, 10] . The p55 imparts high processivity onto the holoenzyme by increasing the binding affinity to DNA [4, 11] . The majority of intermolecular contacts occur between the C-terminal region of the 'proximal' p55 monomer (purple in Figure   2 ) and the AID subdomain (Accessory-Interacting Determinant subdomain that extends an an 'arm' around p55) of the p140 catalytic subunit [12] [13] [14] [15] . Pol functions in conjunction with a number of additional replisome components including: 1) topoisomerase, 2) Twinkle mtDNA helicase, 3) mitochondrial RNA polymerase (mtRNAP), 4) RNaseH1, 5) mitochondrial singlestranded DNA-binding protein (mtSSB), and 6) mitochondrial DNA ligase III, (Figure 1 ). Other factors critical for maintenance of the mitochondrial genome include: the multifunctional mitochondrial transcription factor A (TFAM) with important roles in mtDNA replication and packaging, the RecB-type mitochondrial genome maintenance 5'-3' exonuclease 1 (MGME1), the RNA and DNA 5' flap endonuclease (FEN1), and the helicase/nuclease, DNA2 [16] [17] [18] .
MGME1, FEN1, and DNA2 have all been implicated in the mtDNA base excision repair (BER)
pathways [19] . Interestingly, DNA2 has also been demonstrated to stimulate pol activity and co-localizes with Twinkle in the mitochondrial nucleoid, suggesting an important role in the replisome [20, 21] . Most all DNA polymerases start DNA synthesis by extension of an RNA primer that is synthesized by a primase. In mitochondria primase function is afforded by the mitochondrial RNA polymerase (mtRNAP) [22] . Recently the translesion DNA polymeraseprimase, PrimPol, was identified in mitochondria isolated from a human embryonic kidney cell line [23] . Translesion DNA polymerases are specialized enzymes that pass through DNA damage. However, PrimPol is likely required for mtDNA repair and not for mtDNA replication,
as PRIMPOL -/-knockout mice are viable. Of note to human genetic disease, mutation of PRIMPOL is associated with the ocular disorder high myopia [24, 25] .
Overview of human mtDNA replication
Replication of animal cell mtDNA is complex and slow, taking approximately one hour to synthesize both daughter strands [26] . An asymmetric mode of replicating animal mtDNA daughter strands was proposed in the 1970s [27] . In this strand displacement model of mtDNA replication, two origins of replication direct the replisome to initiate continuous DNA synthesis but initiation is temporally regulated at these locations [26] . First, daughter heavy (H) strand synthesis is initiated at the H-strand origin of replication (O H ) located within the control region ( Figure 1 ). The two mtDNA strands are named heavy and light (L) based on the ability to separate them on alkaline cesium chloride buoyant density gradients [28] . To initiate nascent H-strand synthesis pol must add nucleotides to the 3'-end of an existing RNA primer and in human mitochondria these RNA primers occur at very low frequency [26] . This low frequency implies that either primers are removed very quickly or another initiation mechanism takes place. Evidence supporting the role of human mtRNAP as the mtDNA primase comes from the identification of primers located adjacent to nascent displacement-loop (D-loop) H-strands isolated from human KB cell mitochondria [29] and from in vitro experiments demonstrating that mtRNAP has primase activity [22] . MtRNAP directs polycistronic transcription from H-and Lstrand promoters located in the mtDNA control region (Figure 1 ). Figure   3 . POLG disorders are very polymorphic in regard to the timing of presentation, organ-systems affected and overall symptoms. These disorders are currently defined by at least six major phenotypes of neurodegenerative disease that include: AHS, MCHS, myoclonic epilepsy myopathy sensory ataxia (MEMSA), the ataxia neuropathy spectrum (ANS), autosomal recessive PEO (arPEO), and autosomal dominant PEO (adPEO) [7, 8, 41, 42] . Also, alteration of the (CAG) 10 repeat in the 2 nd exon of POLG has been implicated in male infertility, testicular cancer, and Parkinsonism [8] . The POLG gene is unique in regard to the number of pathogenic mutations spread out over the gene and by the variety of diseases that they cause.
PEO is a mitochondrial disorder associated with mtDNA deletions and point mutations Alpers syndrome typically occurs as an autosomal recessive mtDNA depletion disorder that affects children and young adults. It is a devastating disease characterized by psychomotor retardation, hepatic failure, and intractable seizures, as well as tissue-specific mtDNA depletion.
Alpers patients rarely survive past 10 years of age.
In an attempt to understand the disease progression and severity, biochemical and the Y955C substitution increases nucleotide misinsertion errors 10-to 100-fold in the absence of exonucleolytic proofreading [54] , and the Y955C pol displays relaxed discrimination during incorporation of 8-oxo-dGTP or translesion synthesis opposite 8-oxo-dG [55] . A mouse transgenic model with the Y955C POLG allele targeted to the heart resulted in cardiomyopathy, loss of mtDNA, and enlarged hearts [56] . These experiments strongly suggest that large reductions in pol polymerase activity are sufficient to cause mitochondrial dysfunction that is central to POLG-related disease.
Disorders of POLG2, the mtDNA polymerase p55 processivity subunit
The first POLG2 mutation described (c.1352G>A; p.G451E) was identified in a late onset PEO patient with multiple mtDNA deletions in muscle and ptosis [57] . Biochemical experiments revealed that the G451E p55 homodimer completely failed to stimulate pol due to an inability to bind p140 [57, 58] . The second case also involved a late onset adPEO patient with mtDNA deletions and harbored a c.1207-1208ins24 mutation, causing mis-splicing and skipping of exon 7, thus impairing the C-terminal domain required for enzyme processivity [38] .
Seven more novel heterozygous mutations in POLG2 were identified in a cohort of 112 patients suspected of POLG involvement but lacking POLG mutations [58] . Recombinant homodimeric proteins harboring these alterations were assessed for stimulation of processive DNA synthesis, binding to the catalytic subunit, binding to dsDNA and self-dimerization [58, 59] .
In this analysis, G103S, L153V, D386E and S423Y displayed wild-type behavior, while P205R
and R369G had reduced stimulations of processivity. The L475DfsX2 variant was unable to bind the p140 catalytic subunit [58, 59] .
Because currently identified POLG2 patients harbor heterozygous mutations, and because monomers within the p55 homodimer do not readily dissociate, the patients should harbor a mixture of p55 molecules: 25% WT homodimers, 25% variant homodimers, and 50%
heterodimers [4] . Using a tandem affinity strategy and biochemistry to study p55 heterodimers we showed that one p55 disease variant, G451E, is dominant negative and associates with a wild-type p55 monomer in pol to poison the enzyme's activity. These results are in agreement with previous observations, that homodimeric G451E substitutions are located in critical regions of both monomers that interact with p140 [15] and that these substitutions result in decreased processivity due to compromised p55-p140 subunit interaction [57, 58] .
In contrast to the WT/G451E p55 heterodimer, L475DfsX2, P205R, and R369G p55
heterodimers maintain WT levels of processivity in vitro. However, the P205R and L475DfsX2 p55 disease variants failed to localize to mitochondrial nucleoids in vivo when tagged with GFP.
Furthermore, homogenous preparations of P205R and L475DfsX2 formed aberrant reducible multimers in vitro. This suggests that abnormal protein folding or aggregation or both contribute to the pathophysiology in patients harboring these mutations. Lastly, bioenergetics analysis in HEK293 cell lines stably expressing mutant p55 proteins utilizing the Seahorse Extracellular Flux Analyzer demonstrated significant decreases in reserve respiratory capacity [4] . We predict that the various defects associated with p55 disease variants ultimately result in diminished cellular energy reserves and by extension mitochondrial disease.
While the catalytic subunit has been shown to be essential for embryo development [60] , genetic data regarding the processivity subunit has been lacking in mammalian systems. To address the role of POLG2 in vertebrates we generated heterozygous (Polg2 Electron microscopy demonstrated severe ultra-structural defects and loss of organized cristae in mitochondria of the Polg2 -/-embryos as well as an increase in lipid accumulation compared with both WT and Polg2 +/-embryos. This data indicates that p55 and p140 function is essential for mammalian embryogenesis and mtDNA replication.
Disorders of Twinkle, the mtDNA helicase
The mitochondrial replicative helicase, referred as the Twinkle helicase, is encoded by the Twinkle gene (also known as PEO1 or C10orf2) and was originally identified by Spelbrink and co-workers in 2001 [62] . Electron microscopy and small angle X-ray scattering were recently utilized to examine the structure of Twinkle and revealed it forms hexamers and heptamers of variable conformation [63] . Missense mutations in Twinkle co-segregate with mitochondrial disorders such as adult-onset PEO, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. Screening of Twinkle in individuals with adPEO, associated with multiple mtDNA deletions, identified 11 different mutations that co-segregated with the disorder in 12 affected families [62] . At least 23 additional missense mutations in Twinkle associated diseases have been reported in adPEO [64, 65] . Although mutations in Twinkle are mainly associated with adPEO, several reports have described recessive mutations as a cause of either epileptic encephalopathy with mtDNA depletion or infantile-onset spinocerebellar ataxia [66] [67] [68] .
Expression of this protein in baculovirus, purification, and characterization has verified that Twinkle functions as a 5'-3' DNA helicase and its activity is stimulated by mtSSB [69] .
Furthermore, when the core replisome components are combined in an in vitro reaction (containing pol p140 + pol p55, Twinkle, and mtSSB) the reconstituted system efficiently utilize dsDNA mini-circle templates to synthesize ssDNA molecules greater than 15,000 nucleotides in length, about the size of human mtDNA [70] . Overexpression of dominant disease variants of the mtDNA helicase in cultured human or Schneider cells results in stalled mtDNA replication or depletion of mtDNA [71] [72] [73] , which emulates the disease state. Two of five adPEO mutants exhibited a dominant negative phenotype with mtDNA depletion in Schneider cells [72] . Disease mutations in the linker region were shown to disrupt protein hexamerization and abolish DNA helicase activity [74] . Four mutations in the N-terminal domain demonstrated a dramatic decrease in ATPase activity [75] .
A comprehensive study of 20 recombinant disease variants overproduced and purified from Escherichia coli has reveled mild to moderate defects in helicase activity and ATP hydrolysis [37] . Utilizing optimized in vitro conditions some of the 20 variants also displayed partial reductions in DNA binding affinity and thermal stability. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of the Twinkle gene.
A mouse model of Twinkle deficiency has been produced by transgenic expression of a
Twinkle cDNA with an autosomal dominant mutation found in patients [76, 77] . These mice developed progressive respiratory chain deficiency at 1 year of age in skeletal muscle, cerebellar Pukinje cells, and hippocampal neurons. The affected cells accumulated multiple mtDNA deletions. These 'Deletor' mice recapitulates many of the symptoms associated with PEO and provides a useful model for further study.
Disorders of RNASEH1
A recent study by Reyes et al. examined three families with recessive inheritance patterns consistent with affected individuals harboring causative homozygous or compoundheterozygous mutations [78] . Whole-exome sequencing revealed mutations in the RNASEH1 gene. RNASEH1 encodes the nuclear and mitochondrial isoforms of RNaseH1 endoribonuclease, which hydrolyze RNA strands in RNA-DNA hybrids containing a stretch of at least four ribonucleotides [79] . Two in-frame methionine codons are located at the 5'-end of the gene and translation from the first produces RNaseH1 harboring a MTS that localizes it to the mitochondria while the second targets RNaseH1 to the nucleus [79, 80] . All of the mitochondrial disease-associated amino acid substitutions map within the RNaseH1 catalytic domain.
Recombinant disease variants harboring these substitutions had significantly reduced endoribonuclease activity relative to WT RNaseH1. Two patients from two separate families were found to harbor compound-heterozygous mutations and four other affected siblings from a third family were found to harbor identical homozygous substitutions. All affected individuals presented with chronic PEO and exercise intolerance in their twenties. As the disorder progressed they also exhibited muscle weakness, dysphagia, impaired gait coordination, dysmetria and dysarthria. Muscle biopsies revealed impaired mitochondrial respiratory chain complexes as well as ragged-red and COX-negative fibers. Presumably, virtually all damage was mitochondrial genomic alterations in these patients (and in RNASEH1 KO mice [80] ) due to a compensatory function of nuclear RNaseH2, which is not found within the mitochondrion.
Disorders of DNA2, Dna2 Helicase/nuclease
While mutations in POLG are the major cause of mtDNA-deletion, disorders diagnosis is typically only achieved in about half of the cases. In a cohort of patients suffering from childhood-and adult-onset mtDNA-deletion disorders, Ronchi and co-workers identified mutations in the gene encoding the mitochondrial helicase/nuclease DNA2 [81] . Human Dna2 localizes to both the nucleus and to mitochondria and is required for mtDNA and nuclear DNA maintenance [21] . Dna2 participates in the mtDNA long-patch BER pathway (LP-BER) and the LP-BER machinery repairs small lesions such as those induced by oxidative damage. The four patients identified in this study harbored heterozygous DNA2 mutations associated with hallmark mtDNA-deletion disease molecular and histochemical defects, mtDNA deletions and COX-negative muscle fibers respectively [81] . Recombinant forms of these Dna2 disease variants were determined to alter enzymatic nuclease, helicase, and ATPase activities and therefore, theoretically could compromise the LP-BER machinery in vivo.
Disorders of MGME1, MGME1 RecB-type exonuclease
Homozygous nonsense mutations in the MGME1 gene were identified in several individuals with severe, recessive multi-systemic mitochondrial disorder from two families [17] . requires a free 5'-end to a nucleic acid substrate, and prefers ssDNA over dsDNA in vitro [17] .
Conclusions
Many unresolved issues exist in our understanding of mitochondrial syndromes. POLG disorders are especially polymorphic and the question remains as to why some organs and tissues affected in mitochondrial disease and not others? Does mtDNA mutation, deletion, and depletion play a role in tissue specific effects? What role do mtDNA polymorphisms play in mitochondrial disease? Do environmental toxicants influence these disorders? These questions are important areas for future research endeavors and will pave the way to understand disease pathophysiology and eventually to design therapies for treatment. It is clear that nuclear genes functioning in maintenance of mtDNA are commonly altered alleles in mitochondrial disease. Disorders of mtDNA stability are found in core proteins of mtDNA replication or in genes involved in supplying the mitochondrial nucleotide precursors needed for DNA replication (Table 1) . With current next generation sequencing techniques, and our awareness of current disease causing mutations in these genes, the incidence of identified variants in mitochondrial patients will continue to increase with molecular screening. As an example, the number of individuals harboring a recessive pathogenic mutation in POLG has been estimated to approach 2% in the population [82] . However, the varied polymorphic nature of these diseases, as well as the age of presentation due to these gene mutations, stumps our domain, which folds to resemble a "right-hand" comprised of three subdomains: the thumb (green), fingers (dark blue), and palm (red). The p55 processivity subunit dimer is comprised of the proximal monomer (purple) and the distal protomer, light blue. The DNA primer strand is colored red while the template strand is colored pink. The figure was generated using UCSF Chimera and the published 3.3 Å crystal structure PDB ID 4ZTU; Szymanski et al. [15] . [88] .
